SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-001783
Filing Date
2021-09-13
Accepted
2021-09-13 16:01:21
Documents
61
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q elym-20210630.htm   iXBRL 10-Q 2472100
2 EX-31.1 elym-20210630ex31_1.htm EX-31.1 18169
3 EX-31.2 elym-20210630ex31_2.htm EX-31.2 18252
4 EX-32.1 elym-20210630ex32_1.htm EX-32.1 11529
5 EX-32.2 elym-20210630ex32_2.htm EX-32.2 11627
6 GRAPHIC img155832562_0.jpg GRAPHIC 34535
  Complete submission text file 0000950170-21-001783.txt   7247800

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT elym-20210630.xsd EX-101.SCH 41600
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT elym-20210630_pre.xml EX-101.PRE 245792
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT elym-20210630_cal.xml EX-101.CAL 26274
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT elym-20210630_def.xml EX-101.DEF 115831
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT elym-20210630_lab.xml EX-101.LAB 317327
12 EXTRACTED XBRL INSTANCE DOCUMENT elym-20210630_htm.xml XML 1220907
Mailing Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053
Business Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053 425-276-2300
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40708 | Film No.: 211249632
SIC: 2834 Pharmaceutical Preparations